welcome
ScienceDaily

ScienceDaily

Science

Science

Pancreatic cancer immune map provides clues for precision treatment targeting

ScienceDaily
Summary
Nutrition label

77% Informative

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumours may potentially be more susceptible to macrophage-based therapies.

The findings suggest that some tumour cells are more likely to be infiltrated by T cell treatments, while others had myeloid cell infiltration.

This means that macrophages could be suitable for future immunotherapeutic treatments in some cases.

Birmingham is running the mRNA vaccine study for pancreatic cancer to see if this can prevent recurrence in Birmingham and have two further studies imminently opening in this disease.

"Any potential breakthroughs in Pancreatic cancer treatment are therefore so important," says Dr Shivan Sivakumar .

VR Score

86

Informative language

92

Neutral language

34

Article tone

formal

Language

English

Language complexity

77

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links